PHARMACEUTICAL RESEARCH SHOULD NOT PANDER TO SHORT-TERM CUSTOMER DEMANDS, EX-SANDOZ, CORANGE EXEC LINK SAYS: MEDICAL NEEDS OF 2005-2010 TAKE VISION TO PREDICT
Executive Summary
Pharmaceutical companies should be wary of allowing customer demands to drive research and development, former Sandoz Chairman and Corange CEO Max Link, PhD, suggested at the Third Annual Princeton Conference on Drug Development sponsored by the Center for the Study of Drug Development May 5 in Princeton, N.J.